Dozens of generic versions of the drugs are now expected to enter the market, at significantly lower prices than Novos
FDA and Novo Nordisk (manufacturer of Ozempic) are testing the seized products and do not yet have information about the drugs identity, quality, or safety
Many people living with arthritis struggle with pain, stiffness, and reduced mobility that can significantly affect daily life
despite being taken as a daily pill rather than injection, it contains the same active ingredient and allegedly carries similar risks Mounjaro (tirzepatide): Manufactured by Eli Lilly and approved in May 2022, this medication works as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, offering enhanced blood sugar control and weight loss effects but also allegedly causing severe gastrointestinal injuries similar to semaglutide products Trulicity (dulaglutide): Eli Lillys once-weekly GLP-1 injection approved in 2014 for type 2 diabetes
Pharmacists Perspective Faryal Faisal, PharmD Neither medication should be stopped abruptly without medical guidance
Does it have any side effects
